Literature DB >> 6621770

Relationship between changes in free cholesterol and pyrophosphomevalonate decarboxylase activity during myelination.

C Marco, D Gonzalez-Pacanowska, A Linares, E Garcia-Peregrin.   

Abstract

The patterns of cholesterol content in chick brain and liver were studied during embryonic development and compared with the variations in the specific activities of mevalonate-activating enzymes during the same period. Total cholesterol content in both embryonic chick brain and liver increased during incubation. The relative percentage of free cholesterol was always maintained over 85% in brain, while in liver this percentage decreased to less than 10% during the later days of incubation. A straight parallelism was observed between free cholesterol and pyrophosphomevalonate decarboxylase activity in the embryonic brain. On the other hand, the hepatic decarboxylase exhibited a lower specific activity than in brain and did not show significant variations throughout the same period of incubation. Changes in brain pyrophosphomevalonate decarboxylase activity were more pronounced than those observed in both mevalonate kinase and phosphomevalonate kinase activities, in spite of that the specific activity of decarboxylase was the lowest of the three mevalonate-activating enzymes, suggesting that this reaction is one rate-limiting step for cholesterogenesis during myelination.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6621770     DOI: 10.1007/bf00964728

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  21 in total

1.  Decarboxylation of mevalonate pyrophosphate is one rate-limiting step in hepatic cholesterol synthesis in suckling and weaned rats.

Authors:  C K Ramachandran; S N Shah
Journal:  Biochem Biophys Res Commun       Date:  1976-03-08       Impact factor: 3.575

2.  [The distribution of various lipid fractions during the development of the brain in the rat].

Authors:  P MANDEL; R BIETH
Journal:  Bull Soc Chim Biol (Paris)       Date:  1951

3.  Activity of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in brains of adult and 7-day-old rats.

Authors:  M M Sudjic; R Booth
Journal:  Biochem J       Date:  1976-02-15       Impact factor: 3.857

Review 4.  Brain sterol metabolism.

Authors:  A N Davison
Journal:  Adv Lipid Res       Date:  1965

5.  Rhythmic activity of utilization of mevalonate for biogenesis of cholesterol.

Authors:  C S Bhat; T Ramasarma
Journal:  Biochem Biophys Res Commun       Date:  1977-01-24       Impact factor: 3.575

Review 6.  Regulation of HMG-CoA reductase.

Authors:  V W Rodwell; J L Nordstrom; J J Mitschelen
Journal:  Adv Lipid Res       Date:  1976

7.  Inhibition of rat liver mevalonate pyrophosphate decarboxylase and mevalonate phosphate kinase by phenyl and phenolic compounds.

Authors:  C Shama Bhat; T Ramasarma
Journal:  Biochem J       Date:  1979-07-01       Impact factor: 3.857

8.  Secondary regulatory sites in rat liver cholesterol biosynthesis: role of 5-pyrophosphomevalonate decarboxylase.

Authors:  A M Jabalquinto; E Cardemil
Journal:  Lipids       Date:  1980-03       Impact factor: 1.880

9.  Metabolism of cholesterol in the tissues and blood of the chick embryo.

Authors:  W E Connor; R Johnston; D S Lin
Journal:  J Lipid Res       Date:  1969-07       Impact factor: 5.922

10.  Brain phosphorylation and decarboxylation of mevalonic acid in the neonatal chick.

Authors:  D Gonzalez-Pacanowska; J García-Martinez; E García-Peregrín
Journal:  Enzyme       Date:  1981
View more
  10 in total

1.  Effect of clofibrate on brain mevalonate-5-pyrophosphate decarboxylase.

Authors:  M F Zafra; S Riquelme; M Castillo; E Garcia-Peregrin
Journal:  Neurochem Res       Date:  1987-09       Impact factor: 3.996

2.  Inhibition of sterol but not fatty acid synthesis by valproate in developing rat brain in vivo.

Authors:  J P Bolaños; J M Medina; D H Williamson
Journal:  Biochem J       Date:  1990-11-15       Impact factor: 3.857

3.  Differential response of chick liver and brain membranes to short ethanol treatment.

Authors:  C Marco; F Ceacero; D Gonzalez-Pacanowska; E Garcia-Peregrin; J L Segovia
Journal:  Neurochem Res       Date:  1986-09       Impact factor: 3.996

4.  Mevalonate 5-pyrophosphate decarboxylase in isolated villus and crypt cells of chick intestine.

Authors:  J Iglesias; D Gonzalez-Pacanowska; G Caamaño; E Garcia-Peregrin
Journal:  Lipids       Date:  1988-04       Impact factor: 1.880

5.  Effect of lipid content of diet on cholesterol content and cholesterogenic enzymes of European eel liver.

Authors:  C Burgos; M F Zafra; M Castillo; E Garcia-Peregrin
Journal:  Lipids       Date:  1993-10       Impact factor: 1.880

6.  Dietary fish oil reduces cholesterol and arachidonic acid levels in chick plasma and very low density lipoprotein.

Authors:  M Castillo; F Amalik; A Linares; E García-Peregrín
Journal:  Mol Cell Biochem       Date:  1999-10       Impact factor: 3.396

7.  Utilization of ketone bodies by chick brain and spinal cord during embryonic and postnatal development.

Authors:  A Linares; G J Caamaño; R Diaz; F J Gonzalez; E Garcia-Peregrin
Journal:  Neurochem Res       Date:  1993-10       Impact factor: 3.996

8.  Metabolism of intracerebrally injected mevalonate in brain of suckling and young adult rats.

Authors:  R C Johnson; S N Shah
Journal:  Neurochem Res       Date:  1985-05       Impact factor: 3.996

9.  Effect of phenylalanine derivatives on the main regulatory enzymes of hepatic cholesterogenesis.

Authors:  M Castillo; M Martinez-Cayuela; M F Zafra; E Garcia-Peregrin
Journal:  Mol Cell Biochem       Date:  1991-06-26       Impact factor: 3.396

10.  Inhibition of brain and liver 3-hydroxy-3-methylglutaryl-CoA reductase and mevalonate-5-pyrophosphate decarboxylase in experimental hyperphenylalaninemia.

Authors:  M Castillo; M F Zafra; E Garcia-Peregrin
Journal:  Neurochem Res       Date:  1988-06       Impact factor: 3.996

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.